Suppr超能文献

CX3CR1基因多态性(V249I和T280M)与年龄相关性黄斑变性的关联:一项荟萃分析。

Association of CX3CR1 (V249I and T280M) polymorphisms with age-related macular degeneration: a meta-analysis.

作者信息

Li Dan, Peng XiaoYan, Sun HuiYu

机构信息

Department of Ophthalmology, Beijing Di Tan Hospital, Capital Medical University, Beijing, China.

Beijng Tongren Eye Center, Beijing Ophthalmology and Visual Sciences Key Lab, Beijing Tongren Hospital.

出版信息

Can J Ophthalmol. 2015 Dec;50(6):451-60. doi: 10.1016/j.jcjo.2015.08.010.

Abstract

OBJECTIVE

Studies investigating the associations between CX3CR1 genetic polymorphisms and age-related macular degeneration (AMD) have reported controversial results. Therefore, this meta-analysis aims to clarify the effects of CX3CR1 T280M and V249I polymorphisms on AMD risk.

DESIGN

Meta-analysis.

PARTICIPANTS

Results from six studies were pooled in the meta-analysis.

METHODS

Relevant studies were selected through an extensive search of PubMed, EMBASE, and the Web of Science databases. Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using random-effects model.

RESULTS

Six studies with were included in this systematic review and meta-analysis. There was no significant association between CX3CR1 T280M polymorphism and risk of AMD under all genetic models (TT vs

CC/CT: OR = 1.57, 95% CI = 0.87-2.84; CC vs TT/CT: OR = 0.75, 95% CI = 0.54-1.06; TT vs CC: OR = 0.58, 95% CI = 0.30-1.144; CT vs CC: OR = 1.25, 95% CI = 0.91-1.70). The CX3CR1 V249I polymorphism also did not significantly affect the AMD risk (AA vs

GG/AG: OR = 1.23, 95% CI = 0.98-1.55; AG/AA vs GG: OR = 0.56, 95% CI = 0.29-1.07; AA vs GG: OR = 1.43, 95% CI = 0.97-2.09; AG vs GG: OR = 1.07, 95% CI = 0.85-1.36).

CONCLUSIONS

This meta-analysis suggested that CX3CR1 T280M and V249I polymorphisms may not be associated with an increased risk of AMD based on current published data. Given the limited sample size, the finding on CX3CR1 polymorphisms needs further investigation.

摘要

目的

关于CX3CR1基因多态性与年龄相关性黄斑变性(AMD)之间关联的研究报告了相互矛盾的结果。因此,本荟萃分析旨在阐明CX3CR1 T280M和V249I多态性对AMD风险的影响。

设计

荟萃分析。

参与者

六项研究的结果被纳入荟萃分析。

方法

通过广泛检索PubMed、EMBASE和科学网数据库来选择相关研究。使用随机效应模型计算合并比值比(OR)和95%置信区间(CI)。

结果

六项研究被纳入本系统评价和荟萃分析。在所有遗传模型下,CX3CR1 T280M多态性与AMD风险之间均无显著关联(TT与CC/CT比较:OR = 1.57,95% CI = 0.87 - 2.84;CC与TT/CT比较:OR = 0.75,95% CI = 0.54 - 1.06;TT与CC比较:OR = 0.58,95% CI = 0.30 - 1.144;CT与CC比较:OR = 1.25,95% CI = 0.91 - 1.70)。CX3CR1 V249I多态性也未显著影响AMD风险(AA与GG/AG比较:OR = 1.23,95% CI = 0.98 - 1.55;AG/AA与GG比较:OR = 0.56,95% CI = 0.29 - 1.07;AA与GG比较:OR = 1.43,95% CI = 0.97 - 2.09;AG与GG比较:OR = 1.07,95% CI = 0.85 - 1.36)。

结论

本荟萃分析表明,基于目前已发表的数据,CX3CR1 T280M和V249I多态性可能与AMD风险增加无关。鉴于样本量有限,关于CX3CR1多态性的这一发现需要进一步研究。

相似文献

1
Association of CX3CR1 (V249I and T280M) polymorphisms with age-related macular degeneration: a meta-analysis.
Can J Ophthalmol. 2015 Dec;50(6):451-60. doi: 10.1016/j.jcjo.2015.08.010.
2
Associations Between the T280M and V249I SNPs in CX3CR1 and the Risk of Age-Related Macular Degeneration.
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5590-8. doi: 10.1167/iovs.15-16830.
5
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.
6
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.
Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2.
8
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5.
9
Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration.
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD015804. doi: 10.1002/14651858.CD015804.pub2.
10
Study of Polymorphisms in CX3CR1, PLEKHA1 and VEGF genes as risk factors for age-related macular degeneration in Indian patients.
Arch Med Res. 2014 Aug;45(6):489-94. doi: 10.1016/j.arcmed.2014.07.005. Epub 2014 Jul 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验